| Factor Information | |
|---|---|
| Data ID | 2743 |
| Factor | Peak oxygen consumption (pV02) |
| Description | In patients with acquired heart disease, cardiopulmonary exercise testing with measures of maximal oxygen consumption heart rate response is an excellent predictor of clinical outcomes. |
| Biomarker | NA |
| Classification | E10 (physiological factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | The aim of the study was to examine the value of cardiopulmonary exercise testing including measures of heart rate response in predicting the outcomes of pregnancy in women with CHD. |
| Conclusion | On exercise testing, the mean for the pV02 was 24.5± 5.5 mL/kg/min and the %MPHR was 85.1±10.7. The mean CRI was abnormal at 0.75 (normal >0.8). The pV02 was lower in those with chronotropic incompetence. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 618 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/D-TGA, AS |
| Reference | |
|---|---|
| PMID | 21484600 |
| Year | 2011 |
| Title | The role of exercise testing for predicting pregnancy outcomes in women with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | pregnant women | |
| Source | Data | |
| Region | California, USA | |
| Method | cardiopulmonary exercise testing | |
| Race | North America | |
| Disease History | arrhythmias | |
| Treatment History | N/A | |
| Group | pregnant women with CHD(Treatment) | N/A(Control) |
| Number | 89 pregnancies in 83 women | N/A |
| Age | 28 years | N/A |
| Gender (Male: Female) | 0:83 | N/A |
| Marker Level | 24.5±5.5 mL/kg/min | N/A |
